Murali Janakiram - Publications, H-index & Citations

Murali Janakiram

city of hope

31H指数

276论文数

5.1K被引数

收录论文 67

发表时间

Association between diabetic control and progression of monoclonal gammopathy of undetermined significance to multiple myeloma 糖尿病控制与意义未明的单克隆丙种球蛋白病进展为多发性骨髓瘤之间的关系

Blood Cancer Journal

IF11.6

2026-08-03

OAAI

Lawrence Liu; Byron Sigel; Mei Wang; Nikhil Grandhi; Martin W. Schoen; Kristen M. Sanfilippo; Kenneth R. Carson; Murali Janakiram; Tzeyu L. Michaud; Graham A. Colditz; Theodore S. Thomas; Su-Hsin Chang

Impact of extramedullary plasmacytoma on outcomes in patients with relapsed refractory multiple myeloma treated with talquetamab: U.S. Myeloma Immunotherapy Consortium

Blood Cancer Journal

IF11.6

2026-07-27

OAAI

Aimaz Afrough; Oren Pasvolsky; Andrew J. Portuguese; Saurabh Zanwar; Mahmoud R. Gaballa; Aishwarya Sannareddy; Danai Dima; Utkarsh Goel; Hossam M. Ali; Kelley Julian; Andre De Menezes Silva Corraes; Murali Janakiram; Scott Goldsmith; James A. Davis; Kimberly Green; Noa Biran; Lindsay Fogel; Eli Zolotov; Megan M. Herr; Hamza Hassan; Leyla Shune; Jeries Kort; Christina Ye; Susan Bal; Luciano J. Costa; Laura Joiner; Samer AL Hadidi; Adeel M. Khan; Shahzad Raza; Faiz Anwer; Jack Khouri; Rahul Banerjee; Raffaela Cassano Cassano; Surbhi Sidana; Masooma Shifa Rana; Lekha Mikkilineni; Hitomi Hosoya; Shebli Atrash; Christopher Ferreri; Cindy Varga; Douglas W. Sborov; Shonali Midha; Omar Nadeem; Ariel Grajales-Cruz; Rachid Baz; Brandon Blue; Ciara Freeman; Frederick L. Locke; Krina K. Patel; Yi Lin; Shaji K. Kumar; Doris K. Hansen; Larry D. Anderson Jr; Peter M. Voorhees; Omar Castaneda-Puglianini

Counterpoint: Bispecific antibodies are becoming the preferred standard of care in relapsed/refractory multiple myeloma 反驳观点：双特异性抗体正成为复发/难治性多发性骨髓瘤的首选标准治疗方案

Blood Advances

IF7.1

2026-06-15

OAAI

Murali Janakiram

Real-World Incidence and Management of Non-Immune Effector Cell-Associated Neurotoxicity Syndrome Neurologic Events Following Ciltacabtagene Autoleucel in Multiple Myeloma 真实世界中，Ciltacabtagene Autoleucel治疗多发性骨髓瘤后非免疫效应细胞相关神经毒性综合征神经事件的发病情况与管理

Clinical Epidemiology

IF3.2

2026-05-27

OAAI

Doris K Hansen; Omar Alexis Castaneda Puglianini; Ariel Grajales-Cruz; Saurabh P Nagar; Sabyasachi Ghosh; Victoria Alegria; Kevin C De Braganca; Tamar Lengil; Mukta Sharma; Helen Pai; Matthew Perciavalle; Jessica Maitland; Bruno Emond; Todd Bixby; Zaina P Qureshi; Murali Janakiram

Real-world healthcare resource utilization and clinical outcomes among patients with relapsed/refractory multiple myeloma receiving ciltacabtagene autoleucel after four or more prior lines of therapy in inpatient versus outpatient settings 住院与门诊环境中，接受至少四线治疗后使用cilta-cabtagene autoleucel的复发/难治性多发性骨髓瘤患者的实际医疗资源利用和临床结局

Journal of Medical Economics

IF3

2026-05-23

PREAI

Janakiram, Murali; Fan, Lin; Ghosh, Sabyasachi; Alegria, Victoria; Perciavalle, Matthew; Emond, Bruno; Maitland, Jessica; Bixby, Todd; Nagar, Saurabh P.; Qureshi, Zaina P.; Dima, Danai

Real-World Evaluation of Talquetamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM): An International Myeloma Working Group Immunotherapy Registry Real-World Analysis 真实世界中塔尔奎他马单抗治疗复发/难治性多发性骨髓瘤(RRMM)的疗效评估：国际骨髓瘤工作组免疫治疗登记研究的真实世界分析

American Journal of Hematology

IF9.9

2026-05-19

OAAI

Murali Janakiram; Carlyn R. Tan; Hira Mian; Chiung-Yu Huang; Rakesh Popat; Joaquín Martínez-Lopez; Efsthathios Kastritis; Wee-Joo Chng; Prashant Kapoor; Mrugakshi Dave; Susan Bal; Laurent Garderet; Andre De Menezes Silva Corraes; Christine Riedhammer; Torsten Steinbrunn; Magdalene Corona; Chandramouli Nagarajan; Hermann Einsele; Tom Martin; Amrita Krishnan; Yi Lin

CIBMTR Real-World Comparison of Ide-Cel and Cilta-Cel In relapsed/refractory Multiple Myeloma CIBMTR真实世界研究：Ide-Cel与Cilta-Cel在复发/难治性多发性骨髓瘤中的比较

Transplantation and Cellular Therapy

IF4.4

2026-03-10

PREAI

Maxwell M Krem; Aimaz Afrough; Murali Janakiram; Ruta Brazauskas; Cuyler Huffman; Nausheen Ahmed; Sairah Ahmed; Larry D. Anderson; Aram Bidikian; Frances Cervoni Curet; Scott R. Goldsmith; Yvonne Efebera; Lohith Gowda; Supriya Gupta; Doris K. Hansen; Heather J. Landau; Meera Mohan; Krina K Patel; Carolina Schinke; Marcelo C. Pasquini

Early Mortality with Bispecific Antibody Therapy in RRMM: An IMWG Immunotherapy Database Real-World Analysis 双特异性抗体疗法在RRMM中的早期死亡率：IMWG免疫疗法数据库真实世界分析

Blood Advances

IF7.1

2026-02-26

OAAI

Carlyn Rose Tan; Saad Usmani; Andriy Derkach; Andre de Meneze Silva Corraes; Ricardo Parrondo; Sikander Ailawadhi; Sireesha Asoori; Mrugakshi Dave; Rakesh Popat; Oliver Morjaria; Roman Hajek; Jana Mihalyova; Myo Htut; Murali Janakiram; Alissa Visram; Efstathios Kastritis; Meletios A. Dimopoulos; Joaquin Martinez-Lopez; Chandramouli Nagarajan; Susan Bal

Clinical outcomes with ciltacabtagene autoleucel among patients with relapsed/refractory multiple myeloma after four or more prior lines of therapy overall and among subgroups based on age, frailty, and CRAB symptoms 在既往接受四种或以上治疗方案的患者中，基于年龄、虚弱程度和CRAB症状的亚组中，ciltacabtagene autoleucel治疗复发性/难治性多发性骨髓瘤的临床结局

Current Medical Research and Opinion

IF2.2

2026-02-01

PREAI

Hansen, Doris K.; Puglianini, Omar Alexis Castaneda; Grajales-Cruz, Ariel; Nagar, Saurabh P.; Ghosh, Sabyasachi; Fan, Lin; Alegria, Victoria; De Braganca, Kevin C.; Lengil, Tamar; Sharma, Mukta; Pai, Helen; Perciavalle, Matthew; Emond, Bruno; Maitland, Jessica; Bixby, Todd; Qureshi, Zaina P.; Janakiram, Murali

Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification 评估冰岛筛查、治疗或预防多发性骨髓瘤（iStopMM）模型在多元文化布朗克斯队列中的表现：对未定意义单克隆丙种球蛋白病的风险分层的影响

Blood Cancer Journal

IF11.6

2025-08-21

OAAI

Rajvi Gor; Jeevan Shivakumar; Pallavi Surana; John Wei; Irina Murakhovskaya; Mendel Goldfinger; Noah Kornblum; Lauren Shapiro; Aditi Shastri; Ridhi Gupta; David Levitz; Marina Konopleva; Eric Feldman; Kira Gritsman; R. Alejandro Sica; Ioannis Mantzaris; Amit Verma; Dennis Cooper; Murali Janakiram; Nishi Shah

GPRC5D Bispecific antibody talquetamab-induced dizziness-ataxia syndrome, clinical presentation and management- a case series GPRC5D 双特异性抗体 talquetamab 引起的眩晕-共济失调综合征，临床表现与管理——一项病例系列研究

Blood Cancer Journal

IF11.6

2025-08-11

OAAI

Murali Janakiram; Lawrence Liu; Scott Goldsmith; Azra Borogovac; Sarah Lee; Nitya Nathwani; Michael Rosenzweig; Firoozeh Sahebi; Myo Htut

Acute-phase proteins as biomarkers of inflammation in HIV patients with latent tuberculosis: a prospective study 急性期蛋白作为HIV患者潜伏结核炎症的生物标志物：一项前瞻性研究

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-04-30

OAAI

Kumar, Nathella Pavan; Rajamariyam, M.; Nancy, Arul; Kumar, Bubby S.; Janakiram, M.; Ahamed, Shaik Fayaz; Kumar, Vinod; Vijila, S.; Sekar, S.; Kuralmozhi, R.; Baskaran, Dhanaraj; Hissar, Syed; Babu, Subash

Establishing a successful outpatient CAR T-Cell program with cilta-cel: real-world experience from an expert roundtable 使用cilta-cel建立成功的门诊CAR T细胞计划: 专家圆桌会议的真实世界经验

FUTURE ONCOLOGY

IF2.6

2025-03-01

OAAI

Alsina, Melissa; Dhakal, Binod; Pantin, Jeremy; Huff, Carol A.; Janakiram, Murali

Navigating the Economic Burden of Multiple Myeloma: Insights into Cost-effectiveness of CAR-T and Bispecific Antibody Therapies 导航多发性骨髓瘤的经济负担：CAR-T和双特异性抗体疗法成本效益的见解

CURRENT HEMATOLOGIC MALIGNANCY REPORTS

IF3.3

2025-01-04

OAAI

Praneeth Reddy Keesari; Diana Samuels; Charan Thej Reddy Vegivinti; Yashwitha Sai Pulakurthi; Revathi Kudithi; Meekoo Dhar; Murali Janakiram

Association between glucagon-like peptide-1 receptor agonist use and progression of monoclonal gammopathy of uncertain significance to multiple myeloma among patients with diabetes 胰高血糖素样肽-1受体激动剂的使用与糖尿病患者中多发性骨髓瘤的不确定意义的单克隆丙种球病进展之间的关系

JNCI CANCER SPECTRUM

IF4.1

2024-11-08

OAAI

Grandhi, Nikhil; Liu, Lawrence; Wang, Mei; Thomas, Theodore; Schoen, Martin; Sanfilippo, Kristen; Gao, Feng; Colditz, Graham A.; Carson, Kenneth R.; Janakiram, Murali; Chang, Su-Hsin

Promising Safety and Efficacy Data for Peginterferon Alfa-2a (PEG-IFN) and Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy) in a North American Adult T-Cell Leukemia Lymphoma (NA-ATLL) Cohort of Patients Peginterferon Alfa-2a（PEG-IFN）和Bictegravir/Emtricitabine/Tenofovir Alafenamide（Biktarvy）在北美成人T细胞白血病/淋巴瘤（NA-ATLL）患者队列中的安全性和有效性数据表现出前景。

BLOOD

IF23.1

2024-11-05

PREAI

Dreyfus, Nechama; Cordover, Emma; Pradhan, Kith; Townsend, Latoya S.; Goldfinger, Mendel; Mantzaris, Loannis; Shah, Nishi; Shastri, Aditi; Kornblum, Noah; Cooper, Dennis L.; Gupta, Ridhi; Shapiro, Lauren; Gritsman, Kira; Konopleva, Marina; Mclellan, Beth; Zhen, Simon; de Castro, Alyssa; Lia, Salvatore; Garcia, Virleny; Browne, Roy; Meyerowitz, Eric; Puius, Yoram; Mccort, Margaret; Shi, Yang; Wang, Yanhua; Verma, Amit; Ye, B. Hilda; Janakiram, Murali; Bazarbachi, Abdul-Hamid; Sica, R. Alejandro

Post-Transplantation Cyclophosphamide and Abatacept Graft-Versus-Host-Disease Prophylaxis Shows Improved Outcomes in North American Adult T-Cell Leukemia/Lymphoma 移植后环磷酰胺和阿巴西特移植物抗宿主病预防显示出在北美成人T细胞白血病/淋巴瘤中改善的结局

BLOOD

IF23.1

2024-11-05

PREAI

Nguyen, Julie; Bazarbachi, Abdul-Hamid; Pradhan, Kith; Yan, John; Cordover, Emma; Reef, Daniel K.; Patel, Riya; Al Hamed, Rama; Thakkar, Astha; Rahman, Shafia; Herrera, Diego Adrianzen; Quinn, Ryann; de Castro, Alyssa; Gillick, Kailyn; Mustafa, Jennat; Khatun, Fariha; Lombardo, Amanda; Townsend, Latoya S.; Abreu, Michelly; Chambers, Nicole; Elkind, Richard; Shi, Yang; Wang, Yanhua; Derman, Olga; Gritsman, Kira; Steidl, Ulrich; Goldfinger, Mendel; Kornblum, Noah; Shastri, Aditi; Mantzaris, Ioannis; Rodriguez, Lizamarie Bachier; Moavero, Brittany; Verceles, Jhannine; Czavar, Angela; Shapiro, Lauren; Wang, Trent; Ramos, Juan Carlos; Shah, Nishi; Gupta, Ridhi; Konopleva, Marina; Braunschweig, Ira; Verma, Amit; Ye, B. Hilda; Janakiram, Murali; Cooper, Dennis L.; Sica, R. Alejandro

Venetoclax Alone or in Combination Shows Promising Activity in Preclinical Models and Clinical Cases of Relapsed/Refractory North American Adult T-Cell Leukemia Lymphoma Venetoclax单药或联合用药在北美成人T细胞白血病/淋巴瘤的复发/难治性预临床模型和临床病例中显示出有希望的抗肿瘤活性。

BLOOD

IF23.1

2024-11-05

PREAI

Tanwar, Ankit; Cordover, Emma; Sharma, Shikhar; Tong, Zixuan; Pradhan, Kith; Townsend, Latoya S.; Mantzaris, Ioannis; Goldfinger, Mendel; Shah, Nishi; Shastri, Aditi; Kornblum, Noah; Cooper, Dennis L.; Gupta, Ridhi; Zhen, Simon; Dreyfus, Nechama; Nguyen, Julie; Shapiro, Lauren; Feldman, Eric J.; Braunschweig, Ira; Mclellan, Beth; de Castro, Alyssa; Zang, Xingxing; Bazarbachi, Ali; Janakiram, Murali; Guillen, Erik; Lauvau, Gregoire; Gritsman, Kira; Ye, B. Hilda; Verma, Amit; Liu, Eric; Konopleva, Marina; Sica, R. Alejandro

Case report: Treatment of parkinsonism secondary to ciltacabtagene autoleucel using a combination dopaminergic regimen 病例报告: 使用多巴胺能联合方案治疗继发于ciltacabtagene autoleucel的帕金森氏症

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-09-20

OAAI

Aliakbar, Raya; Manouvakhova, Olga; Wong, Cindy; Htut, Myo; Pulst-Korenberg, Johannes; Janakiram, Murali; Rosenzweig, Michael; Goldsmith, Scott R.; Mason, Xenos L.

Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) Therapy 克隆性造血与嵌合抗原受体T细胞 (CART) 治疗患者的严重细胞因子释放综合征相关

TRANSPLANTATION AND CELLULAR THERAPY

IF4.4

2024-09-01

PREAI

Goldsmith, Scott R.; Shouse, Geoffrey; Wong, F. Lennie; Bosworth, Alysia; Iukuridze, Aleksi; Chen, Sitong; Rhee, June-Wha; Mei, Matthew; Htut, Myo; Janakiram, Murali; Forman, Stephen J.; Pillai, Raju; Budde, L. Elizabeth; Armenian, Saro H.

研究方向